Full Text
Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

Abstract

Authors

GH Elsisi

Back to Volume 20, Issue 9
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×